2 publishers · first seen Mon, 09 Nov 2026 00:00 UTC · updated Tue, 10 Nov 2026 05:51 UTC
The National Pharmaceutical Pricing Authority (NPPA) has implemented revised maximum retail prices (MRPs) for 1,364 anti-cancer drug formulations, aiming to reduce costs for patients. As of November 9, 2026, 85 pharmaceutical companies reported price reductions for these formulations, with 679 brands seeing cuts of over 50%, and the highest reduction at 96.45%. The government estimates annual savings of approximately Rs 3,540.38 crore for consumers. However, Hyderabad chemists anticipate delays in the availability of these cheaper medicines due to logistical and financial challenges.
Content auto-generated. May contain inaccuracies.